| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.22B | 169.40B | 140.70B | 119.82B | 111.11B | 93.09B |
| Gross Profit | 22.60B | 25.98B | 19.42B | 19.80B | 16.59B | 14.94B |
| EBITDA | 12.78B | 14.75B | 9.79B | 10.65B | 8.16B | 7.03B |
| Net Income | 7.62B | 8.47B | 5.64B | 6.46B | 4.51B | 4.84B |
Balance Sheet | ||||||
| Total Assets | 153.18B | 147.66B | 144.22B | 126.00B | 129.99B | 116.42B |
| Cash, Cash Equivalents and Short-Term Investments | 16.36B | 16.26B | 15.67B | 19.99B | 22.82B | 22.01B |
| Total Debt | 42.10B | 30.80B | 38.62B | 22.43B | 31.95B | 30.46B |
| Total Liabilities | 83.56B | 71.65B | 75.38B | 59.46B | 69.55B | 58.89B |
| Stockholders Equity | 69.61B | 76.00B | 68.83B | 66.53B | 60.43B | 57.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.59B | -18.04B | 7.83B | 1.47B | 13.24B |
| Operating Cash Flow | 0.00 | 9.85B | -17.19B | 10.23B | 4.15B | 15.84B |
| Investing Cash Flow | 0.00 | 1.92B | -255.00M | -1.18B | -3.07B | -1.55B |
| Financing Cash Flow | 0.00 | -11.16B | 13.15B | -11.86B | -253.00M | -14.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥133.17B | 8.72 | ― | 2.81% | 5.14% | 18.79% | |
79 Outperform | ¥130.77B | 15.33 | ― | 2.14% | 4.78% | 50.65% | |
68 Neutral | ¥75.69B | 20.51 | ― | 8.02% | -4.15% | -16.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥80.30B | 9.52 | ― | 3.63% | 20.40% | 50.00% | |
60 Neutral | ¥110.19B | 12.95 | ― | 3.81% | -9.72% | -31.50% | |
59 Neutral | ¥102.62B | 10.71 | ― | 3.13% | 10.13% | 13.31% |